Details for: CTNNAL1
Associated with
Significant Cells
Cell Significance Index (CSI) scores for the chosen context(s)
-
CSI 34.84rCSI 47.4%PRS 77.06
-
CSI 33.98rCSI 67.47%PRS 62.72
-
CSI 24.06rCSI 20.17%PRS 69.62
-
CSI 17.96rCSI 27.75%PRS 64.15
-
CSI 16.83rCSI 41.67%PRS 64.22
-
CSI 14.15rCSI 34.39%PRS 45.52
-
CSI 13.45rCSI 36.96%PRS 77.25
-
CSI 11.69rCSI 61.46%PRS 70.21
-
CSI 10.9rCSI 41.19%PRS 47.7
-
CSI 8.75rCSI 10.82%PRS 62.44
-
CSI 8.44rCSI 26.39%PRS 48.77
-
CSI 7.82rCSI 53.67%PRS 77.57
-
CSI 6.9rCSI 9.56%PRS 65.87
-
CSI 6.68rCSI 13.86%PRS 62.77
-
CSI 6.54rCSI 17.22%PRS 82.49
-
CSI 6.43rCSI 10.99%PRS 82.61
-
CSI 6.39rCSI 5.29%PRS 68.11
-
CSI 5.92rCSI 13.27%PRS 47.7
-
CSI 5.85rCSI 34.46%PRS 48.23
-
CSI 5.83rCSI 42.61%PRS 80.36
-
CSI 5.77rCSI 6.19%PRS 65.6
-
CSI 5.49rCSI 6.68%PRS 73.12
-
CSI 5.48rCSI 24.33%PRS 65.6
-
CSI 5.45rCSI 4.79%PRS 53.62
-
CSI 5.34rCSI 4.6%PRS 70.32
-
CSI 5.14rCSI 14.88%PRS 76.65
-
CSI 4.94rCSI 8.54%PRS 55.96
-
CSI 4.92rCSI 5.14%PRS 65.9
-
CSI 4.82rCSI 6.14%PRS 71.84
-
CSI 4.8rCSI 7.65%PRS 57.94
-
CSI 4.76rCSI 4.23%PRS 63.51
-
CSI 4.53rCSI 6.17%PRS 57.13
-
CSI 4.46rCSI 3.31%PRS 58.43
-
CSI 4.35rCSI 7.72%PRS 38.5
-
CSI 4.34rCSI 16.24%PRS 57.56
-
CSI 4.18rCSI 4.33%PRS 71.42
-
CSI 4.17rCSI 8.46%PRS 44.43
-
CSI 4.05rCSI 9.25%PRS 57.34
-
CSI 3.91rCSI 5.64%PRS 74.44
-
CSI 3.9rCSI 12.01%PRS 73.28
-
CSI 3.73rCSI 10.17%PRS 81.44
-
CSI 3.58rCSI 5.24%PRS 70.64
-
CSI 3.58rCSI 16.42%PRS 75.21
-
CSI 3.52rCSI 30.29%PRS 52.82
-
CSI 3.51rCSI 3.32%PRS 64.82
-
CSI 3.51rCSI 6.84%PRS 68.65
-
CSI 3.47rCSI 9.87%PRS 63.35
-
CSI 3.44rCSI 3.39%PRS 68.54
-
CSI 3.44rCSI 6.56%PRS 79.81
-
CSI 3.36rCSI 4.76%PRS 62.02
-
CSI 3.35rCSI 4.48%PRS 74.32
-
CSI 3.25rCSI 5.19%PRS 69.87
-
CSI 3.24rCSI 3.39%PRS 62.14
-
CSI 3.23rCSI 6.11%PRS 82.57
-
CSI 3.21rCSI 2.78%PRS 70.69
-
CSI 3.19rCSI 5.63%PRS 62.3
-
CSI 3.17rCSI 4.87%PRS 59.95
-
CSI 3.16rCSI 2.62%PRS 65.19
-
CSI 3.13rCSI 2.91%PRS 66.37
-
CSI 3.12rCSI 8.34%PRS 56.58
-
CSI 3.08rCSI 6.18%PRS 54.67
-
CSI 3.06rCSI 3.21%PRS 69.27
-
CSI 3.05rCSI 3.92%PRS 62.6
-
CSI 3.05rCSI 3.66%PRS 63.82
-
CSI 3.04rCSI 4.46%PRS 61.02
-
CSI 2.99rCSI 16.11%PRS 76.87
-
CSI 2.99rCSI 16.87%PRS 50.72
-
CSI 2.96rCSI 4.11%PRS 64.21
-
CSI 2.91rCSI 6.71%PRS 54.26
-
CSI 2.9rCSI 3.35%PRS 58.57
-
CSI 2.9rCSI 4.29%PRS 70.97
-
CSI 2.89rCSI 3.6%PRS 45.19
-
CSI 2.86rCSI 3.42%PRS 46.81
-
CSI 2.83rCSI 4.58%PRS 61.88
-
CSI 2.83rCSI 6.41%PRS 68.83
-
CSI 2.81rCSI 2.27%PRS 67.43
-
CSI 2.8rCSI 2.7%PRS 56.74
-
CSI 2.79rCSI 3.81%PRS 66.86
-
CSI 2.72rCSI 2.15%PRS 52.56
-
CSI 2.7rCSI 2.19%PRS 65.96
-
CSI 2.66rCSI 3.64%PRS 71.51
-
CSI 2.65rCSI 6.17%PRS 82.44
-
CSI 2.62rCSI 3.04%PRS 72.71
-
CSI 2.6rCSI 12.46%PRS 63.71
-
CSI 2.58rCSI 2.49%PRS 65.4
-
CSI 2.56rCSI 13.77%PRS 76.68
-
CSI 2.49rCSI 6.46%PRS 68.75
-
CSI 2.45rCSI 1.9%PRS 68.4
-
CSI 2.42rCSI 4.97%PRS 82.01
-
CSI 2.36rCSI 6%PRS 55.13
-
CSI 2.36rCSI 3.03%PRS 57.67
-
CSI 2.35rCSI 2.35%PRS 59.09
-
CSI 2.33rCSI 3.42%PRS 77.05
-
CSI 2.31rCSI 5.08%PRS 77.37
-
CSI 2.29rCSI 3.27%PRS 67.61
-
CSI 2.29rCSI 2.95%PRS 48.31
-
CSI 2.28rCSI 5.48%PRS 74.55
-
CSI 2.28rCSI 2.64%PRS 56.16
-
CSI 2.24rCSI 2.63%PRS 67.79
-
CSI 2.22rCSI 3.97%PRS 65.06
-
CSI 0.2rCSI 4.5%PRS 46.1%
-
CSI 0.2rCSI 4.9%PRS 46.9%
-
CSI 0.2rCSI 5.6%PRS 80.4%
-
CSI 0.2rCSI 2.6%PRS 76.8%
-
CSI 0.3rCSI 4.3%PRS 80.4%
-
CSI 0.5rCSI 3.3%PRS 52.2%
-
CSI 0.5rCSI 3.0%PRS 57.4%
-
CSI 0.5rCSI 16.1%PRS 83.5%
-
CSI 0.5rCSI 2.7%PRS 76.5%
-
CSI 0.5rCSI 2.7%PRS 62.4%
-
CSI 0.6rCSI 1.5%PRS 76.1%
-
CSI 0.8rCSI 3.4%PRS 80.2%
-
CSI 0.8rCSI 5.3%PRS 57.5%
-
CSI 0.8rCSI 2.4%PRS 51.2%
-
CSI 0.8rCSI 8.4%PRS 63.5%
-
CSI 0.8rCSI 7.5%PRS 92.4%
-
CSI 0.8rCSI 1.5%PRS 76.0%
-
CSI 0.8rCSI 2.7%PRS 52.5%
-
CSI 0.9rCSI 1.1%PRS 72.0%
-
CSI 0.9rCSI 2.2%PRS 59.6%
-
CSI 0.9rCSI 2.5%PRS 66.7%
-
CSI 0.9rCSI 3.2%PRS 77.5%
-
CSI 0.9rCSI 7.4%PRS 59.1%
-
CSI 1.0rCSI 3.4%PRS 73.4%
-
CSI 1.0rCSI 23.5%PRS 81.5%
-
CSI 1.0rCSI 20.3%PRS 56.2%
-
CSI 1.0rCSI 2.4%PRS 52.8%
-
CSI 1.0rCSI 1.6%PRS 49.0%
-
CSI 1.0rCSI 1.4%PRS 35.2%
-
CSI 1.1rCSI 3.0%PRS 75.9%
-
CSI 1.1rCSI 2.4%PRS 51.6%
-
CSI 1.1rCSI 3.1%PRS 77.6%
-
CSI 1.1rCSI 2.9%PRS 72.4%
-
CSI 1.1rCSI 3.7%PRS 50.5%
-
CSI 1.1rCSI 4.1%PRS 45.4%
-
CSI 1.3rCSI 2.7%PRS 53.3%
-
CSI 1.3rCSI 2.2%PRS 73.7%
-
CSI 1.3rCSI 3.1%PRS 72.6%
-
CSI 1.3rCSI 7.4%PRS 74.3%
-
CSI 1.3rCSI 4.1%PRS 62.8%
-
CSI 1.3rCSI 2.7%PRS 55.4%
-
CSI 1.3rCSI 3.7%PRS 60.9%
-
CSI 1.3rCSI 3.0%PRS 61.5%
-
CSI 1.3rCSI 2.7%PRS 82.2%
-
CSI 1.4rCSI 1.2%PRS 62.7%
-
CSI 1.4rCSI 3.1%PRS 63.9%
-
CSI 1.4rCSI 4.5%PRS 63.4%
-
CSI 1.4rCSI 2.2%PRS 68.2%
-
CSI 1.4rCSI 2.6%PRS 46.1%
-
CSI 1.5rCSI 4.1%PRS 76.2%
-
CSI 1.5rCSI 6.0%PRS 67.5%
-
CSI 1.5rCSI 12.9%PRS 80.4%
-
CSI 1.5rCSI 3.8%PRS 60.7%
-
CSI 1.5rCSI 2.7%PRS 79.7%
-
CSI 1.6rCSI 1.8%PRS 82.9%
-
CSI 1.6rCSI 3.0%PRS 84.1%
-
CSI 1.6rCSI 4.2%PRS 79.1%
-
CSI 1.6rCSI 7.2%PRS 55.6%
-
CSI 1.7rCSI 17.3%PRS 59.5%
-
CSI 1.7rCSI 2.7%PRS 55.2%
-
CSI 1.7rCSI 10.8%PRS 81.7%
-
CSI 1.7rCSI 2.3%PRS 65.8%
-
CSI 1.7rCSI 7.5%PRS 76.8%
-
CSI 1.8rCSI 2.2%PRS 67.4%
-
CSI 1.8rCSI 3.9%PRS 73.2%
-
CSI 1.8rCSI 4.2%PRS 73.6%
-
CSI 1.8rCSI 7.2%PRS 64.8%
-
CSI 1.8rCSI 6.2%PRS 54.1%
-
CSI 1.8rCSI 2.6%PRS 55.2%
-
CSI 1.8rCSI 3.0%PRS 34.4%
-
CSI 1.8rCSI 2.9%PRS 58.2%
-
CSI 1.9rCSI 3.0%PRS 68.2%
-
CSI 1.9rCSI 39.0%PRS 57.6%
-
CSI 1.9rCSI 7.4%PRS 56.2%
-
CSI 1.9rCSI 2.8%PRS 75.7%
-
CSI 2.0rCSI 3.3%PRS 47.1%
-
CSI 2.0rCSI 3.6%PRS 57.2%
-
CSI 2.0rCSI 6.5%PRS 65.3%
-
CSI 2.0rCSI 3.6%PRS 78.4%
-
CSI 2.1rCSI 3.1%PRS 66.4%
-
CSI 2.1rCSI 3.4%PRS 54.7%
-
CSI 2.1rCSI 40.1%PRS 79.6%
-
CSI 2.1rCSI 3.2%PRS 62.0%
-
CSI 2.1rCSI 5.3%PRS 73.2%
-
CSI 2.1rCSI 2.3%PRS 69.4%
-
CSI 2.1rCSI 5.1%PRS 66.1%
-
CSI 2.2rCSI 3.8%PRS 57.9%
-
CSI 2.2rCSI 4.0%PRS 65.1%
-
CSI 2.2rCSI 2.6%PRS 67.8%
-
CSI 2.3rCSI 2.6%PRS 56.2%
-
CSI 2.3rCSI 5.5%PRS 74.6%
-
CSI 2.3rCSI 3.0%PRS 48.3%
-
CSI 2.3rCSI 3.3%PRS 67.6%
-
CSI 2.3rCSI 5.1%PRS 77.4%
-
CSI 2.3rCSI 3.4%PRS 77.1%
-
CSI 2.4rCSI 2.4%PRS 59.1%
-
CSI 2.4rCSI 3.0%PRS 57.7%
-
CSI 2.4rCSI 6.0%PRS 55.1%
-
CSI 2.4rCSI 5.0%PRS 82.0%
-
CSI 2.5rCSI 1.9%PRS 68.4%
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this specific cell.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Fold Change: Represents the ratio of the current Cell Significance Index to the Cell Significance Index Threshold, indicating how much the gene expression has changed compared to a baseline.
Cell Significance Index: Reflects how strongly a gene is expressed in this cell type. Calculated using techniques like effect size estimation and bootstrapping for reliability.
Network Configuration
Explore relationships of the current gene. Select an Interaction Source: 'ONTOLOGY' for shared pathways (GO/Reactome) or 'STRING' for protein-protein interactions. Further refine by selecting context genes and comparing Cell Significance Index (CSI) scores between baseline and target cell types and their specific contexts.
Legend:
- Query Gene
-
Node Color (Target Cell CSI, relative to current network):
- Very High
- High
- Medium
- Low
- Very Low
- CSI N/A
- Node Size: Proportional to Target Cell CSI magnitude
- STRING PPI Edge
- Shared Pathway Edge (ONTOLOGY)
Other Information
This section provides additional information about the gene, including a description generated by an AI language model and details about associated proteins.
Genular Protein ID: 1254336793
Symbol: CTNL1_HUMAN
Name: Alpha-catulin
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 9806841
Title: Identification and chromosomal localization of CTNNAL1, a novel protein homologous to alpha-catenin.
PubMed ID: 9806841
PubMed ID: 10542337
Title: Human alpha-catulin, a novel alpha-catenin-like molecule with conserved genomic structure, but deviating alternative splicing.
PubMed ID: 10542337
PubMed ID: 19054851
Title: Human protein factory for converting the transcriptome into an in vitro-expressed proteome.
PubMed ID: 19054851
DOI: 10.1038/nmeth.1273
PubMed ID: 15164053
Title: DNA sequence and analysis of human chromosome 9.
PubMed ID: 15164053
DOI: 10.1038/nature02465
PubMed ID: 15489334
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
PubMed ID: 15489334
DOI: 10.1101/gr.2596504
PubMed ID: 17974005
Title: The full-ORF clone resource of the German cDNA consortium.
PubMed ID: 17974005
PubMed ID: 12270917
Title: Association of Lbc Rho guanine nucleotide exchange factor with alpha-catenin-related protein, alpha-catulin/CTNNAL1, supports serum response factor activation.
PubMed ID: 12270917
PubMed ID: 18669648
Title: A quantitative atlas of mitotic phosphorylation.
PubMed ID: 18669648
PubMed ID: 23186163
Title: Toward a comprehensive characterization of a human cancer cell phosphoproteome.
PubMed ID: 23186163
DOI: 10.1021/pr300630k
Sequence Information:
- Length: 734
- Mass: 81896
- Checksum: 8756237C73AAEA31
- Sequence:
MAASPGPAGV GGAGAVYGSG SSGFALDSGL EIKTRSVEQT LLPLVSQITT LINHKDNTKK SDKTLQAIQR VGQAVNLAVG RFVKVGEAIA NENWDLKEEI NIACIEAKQA GETIAALTDI TNLNHLESDG QITIFTDKTG VIKAARLLLS SVTKVLLLAD RVVIKQIITS RNKVLATMER LEKVNSFQEF VQIFSQFGNE MVEFAHLSGD RQNDLKDEKK KAKMAAARAV LEKCTMMLLT ASKTCLRHPN CESAHKNKEG VFDRMKVALD KVIEIVTDCK PNGETDISSI SIFTGIKEFK MNIEALRENL YFQSKENLSV TLEVILERME DFTDSAYTSH EHRERILELS TQARMELQQL ISVWIQAQSK KTKSIAEELE LSILKISHSL NELKKELHST ATQLAADLLK YHADHVVLKA LKLTGVEGNL EALAEYACKL SEQKEQLVET CRLLRHISGT EPLEITCIHA EETFQVTGQQ IISAAETLTL HPSSKIAKEN LDVFCEAWES QISDMSTLLR EINDVFEGRR GEKYGYLSLP KPMKNNANLK SLKPDKPDSE EQAKIAKLGL KLGLLTSDAD CEIEKWEDQE NEIVQYGRNM SSMAYSLYLF TRGEGPLKTS QDLIHQLEVF AAEGLKLTSS VQAFSKQLKD DDKLMLLLEI NKLIPLCHQL QTVTKTSLQN KVFLKVDKCI TKTRSMMALL VQLLSLCYKL LKKLQMENNG WVSVTNKDTM DSKT
Genular Protein ID: 1018557309
Symbol: B3KMX6_HUMAN
Name: N/A
UniProtKB Accession Codes:
Database IDs:
Citations:
PubMed ID: 14702039
Title: Complete sequencing and characterization of 21,243 full-length human cDNAs.
PubMed ID: 14702039
DOI: 10.1038/ng1285
Sequence Information:
- Length: 734
- Mass: 81897
- Checksum: 1EC8BA95ED301F94
- Sequence:
MAASPGPAGV GGAGAVYGSG SSGFALDSGL EIKTRSVEQT LLPLVSQITT LINHKDNTKK SDKTLQAIQR VGQAVNLAVG RFVKVGEAIA NENWDLKEEI NIACIEAKQA GETIAALTDI TNLNHLESDG QITIFTDKTG VIKAARLLLS SVTKVLLLAD RVVIKQIITS RNKVLATMER LEKVNSFQEF VQIFSQFGNE MVEFAHLSGD RQNDLKDEKK KAKMAAARAV LEKCTMMLLT ASKTCLRHPN CESAHKDKEG VFDRMKVALD KVIEIVTDCK PNGETDISSI SIFTGIKEFK MNIEALRENL YFQSKENLSV TLEVILERME DFTDSAYTSH EHRERILELS TQARMELQQL ISVWIQAQSK KTKSIAEELE LSILKISHSL NELKKELHST ATQLAADLLK YHADHVVLKA LKLTGVEGNL EALAEYACKL SEQKEQLVET CRLLRHISGT EPLEITCIHA EETFQVTGQQ IISAAETLTL HPSSKIAKEN LDVFCEAWES QISDMSTLLR EINDVFEGRR GEKYGYLSLP KPMKNNANLK SLKPDKPDSE EQAKIAKLGL KLGLLTSDAD CEIEKWEDQE NEIVQYGRNM SSMAYSLYLF TRGEGPLKTS QDLIHQLEVF AAEGLKLTSS VQAFSKQLKD DDKLMLLLEI NKLIPLCHQL QTVTKTSLQN KVFLKVDKCI TKTRSMMALL VQLLSLCYKL LKKLQMENNG WVSVTNKDTM DSKT